在现场用可注射核酸凝进行疫苗接种,用于协同癌症免疫疗法

Fujun Wang1, Miao Xie1, Yangyang Huang1

  • 1School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, Shanghai, 200240, China.

概括

这项研究引入了一种新的核酸水凝疫苗,该疫苗结合了化疗药物,免疫激动剂和免疫检查点抑制剂. 这种创新的癌症疫苗有效触发强烈的抗瘤免疫反应,并在临床前模型中显示出显著的疗效.